Long-term antihypertensive therapy was not associated with risk for cancer, cancer-related mortality or site-specific cancers ...

A new AI tool, AAnet, has discovered five distinct cell types within tumors, offering a deeper look into cancer's inner diversity. This insight could transform how we treat cancer, enabling more ...

Dr. Prantesh Jain and Dr. Joshua Sabari delved into the numerous advances in NSCLC following 2025 ASCO, highlighting the ...

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI ...

ABBV-706 is an ADC targeting SEZ6 developed by AbbVie. It is linked to a topoisomerase 1 inhibitor (TOP1i) via a ...

A team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better ...

This article explores how cancer biomarkers improve early detection, guide treatments and predict outcomes to transform ...

VANCOUVER, BC / ACCESS Newswire / June 20, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that the Co-Founders of ...